Evaluation of antibiotic consumption using WHO -antimicrobial consumption tool and AWaRe classification
Introduction: Antimicrobial resistance is a public health concern with global ramifications. Antibiotic misuse and overuse, are rampant in our country but more alarming is the data on the use of antibiotics primarily because of lack of access is another threat. A majority of the data on drug sales a...
Saved in:
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2024-12-01
|
Series: | Journal of Family Medicine and Primary Care |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/jfmpc.jfmpc_952_24 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1841545817148620800 |
---|---|
author | Julie Birdie Wahlang Reuben P. Syiem Chayna Sarkar Nari M. Lyngdoh Iadarilang Tiewsoh Dhriti K. Brahma Aitilutmon Surong Arky J Langstieh |
author_facet | Julie Birdie Wahlang Reuben P. Syiem Chayna Sarkar Nari M. Lyngdoh Iadarilang Tiewsoh Dhriti K. Brahma Aitilutmon Surong Arky J Langstieh |
author_sort | Julie Birdie Wahlang |
collection | DOAJ |
description | Introduction:
Antimicrobial resistance is a public health concern with global ramifications. Antibiotic misuse and overuse, are rampant in our country but more alarming is the data on the use of antibiotics primarily because of lack of access is another threat. A majority of the data on drug sales and consumption in India comes from the private sector and is typically gathered from private commercial organization. Because data on antibiotic usage in India is rarely reported, the study’s objectives were to estimate antibiotic consumption in ICU patients and also to assess antibiotic usage trends using the WHO AWaRE classification.
Materials and Methods:
A prospective observational study was carried out in the ICU department for six months after obtaining institutional ethics committee approval (P14/2021/14). In-patient records and details on antibiotic prescriptions were collected from the day of admission until they were discharged from the intensive care unit. Data on antibiotic consumption were retrieved from the hospital pharmacy. Descriptive statistics such as frequency, percentages, and means were used to summarize the data. Microsoft Excel 2016 was used for all statistical analyses.
Results:
The results of the study showed that female patients (54%), made up a significant majority of those receiving antimicrobial treatment. The age group between 40–49 years (21.68%) was the most common for those receiving antimicrobial treatment. Surgical prophylaxis (37.34%) emerged as the most common indication. Among the different antimicrobials studied, ceftriaxone 1 gm (108.5 DDD) emerged as the most prescribed antimicrobial. The access group of antibiotics accounted for 55% of the total usage.
Conclusion:
Appropriate use of antibiotics is important to minimize the risk of adverse events and antimicrobial resistance. |
format | Article |
id | doaj-art-4761c6f7898547e79f6afb5db45c9d91 |
institution | Kabale University |
issn | 2249-4863 2278-7135 |
language | English |
publishDate | 2024-12-01 |
publisher | Wolters Kluwer Medknow Publications |
record_format | Article |
series | Journal of Family Medicine and Primary Care |
spelling | doaj-art-4761c6f7898547e79f6afb5db45c9d912025-01-11T10:09:30ZengWolters Kluwer Medknow PublicationsJournal of Family Medicine and Primary Care2249-48632278-71352024-12-0113125805581110.4103/jfmpc.jfmpc_952_24Evaluation of antibiotic consumption using WHO -antimicrobial consumption tool and AWaRe classificationJulie Birdie WahlangReuben P. SyiemChayna SarkarNari M. LyngdohIadarilang TiewsohDhriti K. BrahmaAitilutmon SurongArky J LangstiehIntroduction: Antimicrobial resistance is a public health concern with global ramifications. Antibiotic misuse and overuse, are rampant in our country but more alarming is the data on the use of antibiotics primarily because of lack of access is another threat. A majority of the data on drug sales and consumption in India comes from the private sector and is typically gathered from private commercial organization. Because data on antibiotic usage in India is rarely reported, the study’s objectives were to estimate antibiotic consumption in ICU patients and also to assess antibiotic usage trends using the WHO AWaRE classification. Materials and Methods: A prospective observational study was carried out in the ICU department for six months after obtaining institutional ethics committee approval (P14/2021/14). In-patient records and details on antibiotic prescriptions were collected from the day of admission until they were discharged from the intensive care unit. Data on antibiotic consumption were retrieved from the hospital pharmacy. Descriptive statistics such as frequency, percentages, and means were used to summarize the data. Microsoft Excel 2016 was used for all statistical analyses. Results: The results of the study showed that female patients (54%), made up a significant majority of those receiving antimicrobial treatment. The age group between 40–49 years (21.68%) was the most common for those receiving antimicrobial treatment. Surgical prophylaxis (37.34%) emerged as the most common indication. Among the different antimicrobials studied, ceftriaxone 1 gm (108.5 DDD) emerged as the most prescribed antimicrobial. The access group of antibiotics accounted for 55% of the total usage. Conclusion: Appropriate use of antibiotics is important to minimize the risk of adverse events and antimicrobial resistance.https://journals.lww.com/10.4103/jfmpc.jfmpc_952_24antimicrobial consumptionaware classificationdefined daily dose |
spellingShingle | Julie Birdie Wahlang Reuben P. Syiem Chayna Sarkar Nari M. Lyngdoh Iadarilang Tiewsoh Dhriti K. Brahma Aitilutmon Surong Arky J Langstieh Evaluation of antibiotic consumption using WHO -antimicrobial consumption tool and AWaRe classification Journal of Family Medicine and Primary Care antimicrobial consumption aware classification defined daily dose |
title | Evaluation of antibiotic consumption using WHO -antimicrobial consumption tool and AWaRe classification |
title_full | Evaluation of antibiotic consumption using WHO -antimicrobial consumption tool and AWaRe classification |
title_fullStr | Evaluation of antibiotic consumption using WHO -antimicrobial consumption tool and AWaRe classification |
title_full_unstemmed | Evaluation of antibiotic consumption using WHO -antimicrobial consumption tool and AWaRe classification |
title_short | Evaluation of antibiotic consumption using WHO -antimicrobial consumption tool and AWaRe classification |
title_sort | evaluation of antibiotic consumption using who antimicrobial consumption tool and aware classification |
topic | antimicrobial consumption aware classification defined daily dose |
url | https://journals.lww.com/10.4103/jfmpc.jfmpc_952_24 |
work_keys_str_mv | AT juliebirdiewahlang evaluationofantibioticconsumptionusingwhoantimicrobialconsumptiontoolandawareclassification AT reubenpsyiem evaluationofantibioticconsumptionusingwhoantimicrobialconsumptiontoolandawareclassification AT chaynasarkar evaluationofantibioticconsumptionusingwhoantimicrobialconsumptiontoolandawareclassification AT narimlyngdoh evaluationofantibioticconsumptionusingwhoantimicrobialconsumptiontoolandawareclassification AT iadarilangtiewsoh evaluationofantibioticconsumptionusingwhoantimicrobialconsumptiontoolandawareclassification AT dhritikbrahma evaluationofantibioticconsumptionusingwhoantimicrobialconsumptiontoolandawareclassification AT aitilutmonsurong evaluationofantibioticconsumptionusingwhoantimicrobialconsumptiontoolandawareclassification AT arkyjlangstieh evaluationofantibioticconsumptionusingwhoantimicrobialconsumptiontoolandawareclassification |